review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jang-Young Kim | |
Joong Kyung Sung | |||
P2860 | cites work | Rimonabant for overweight or obesity | Q24244078 |
Enhanced Sarcolemmal FAT/CD36 Content and Triacylglycerol Storage in Cardiac Myocytes From Obese Zucker Rats | Q27832088 | ||
Functional consequences of caspase activation in cardiac myocytes | Q28215640 | ||
Obesity and the risk of heart failure | Q28216583 | ||
Apoptosis in the failing human heart | Q73215232 | ||
Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model | Q73492545 | ||
Myocardial substrate metabolism influences left ventricular energetics in vivo | Q73630681 | ||
Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity | Q79362277 | ||
Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging | Q79953401 | ||
Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study | Q80173759 | ||
Relation between epicardial adipose tissue and left ventricular mass | Q80846003 | ||
Adapted changes in left ventricular structure and function in severe uncomplicated obesity | Q80984809 | ||
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts | Q81039999 | ||
Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss | Q47343464 | ||
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages | Q47735588 | ||
Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass | Q48484294 | ||
Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure | Q48621613 | ||
Alterations of left ventricular myocardial characteristics associated with obesity. | Q51526288 | ||
Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. | Q52126699 | ||
Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. | Q53541654 | ||
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. | Q54542487 | ||
Obesity and the Risk of New-Onset Atrial Fibrillation | Q57073134 | ||
Myocardial contractility and left ventricular function in obese patients with essential hypertension | Q58855539 | ||
Angiotensin II activates programmed myocyte cell death in vitro | Q64389256 | ||
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output | Q70367740 | ||
Obesity and left ventricular diastolic dysfunction | Q71258197 | ||
Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy | Q72351005 | ||
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study | Q72779135 | ||
Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein | Q28377109 | ||
Rat heart is a site of leptin production and action | Q28579489 | ||
Weight-reducing effects of the plasma protein encoded by the obese gene | Q29617934 | ||
Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
Drug treatments for obesity: orlistat, sibutramine, and rimonabant. | Q30359088 | ||
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients | Q33974818 | ||
Lipotoxic diseases | Q34111950 | ||
Obesity and hypertension: two epidemics or one? | Q34311562 | ||
Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease | Q34327447 | ||
Effects of isolated obesity on systolic and diastolic left ventricular function | Q35581622 | ||
Diastolic dysfunction and left atrial volume: a population-based study | Q35998245 | ||
A look between the cardiomyocytes: the extracellular matrix in heart failure | Q36378293 | ||
Lipotoxic heart disease in obese rats: implications for human obesity | Q37117677 | ||
Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years | Q37323106 | ||
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. | Q38321475 | ||
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice | Q38352186 | ||
Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. | Q38352512 | ||
Prevalence of obesity and metabolic syndrome in Korean adults | Q40156500 | ||
Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity | Q42021700 | ||
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats | Q42477638 | ||
Myocardial insulin-mediated glucose uptake and left ventricular geometry | Q43594871 | ||
Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute | Q43814939 | ||
Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. | Q43935460 | ||
Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. | Q44021597 | ||
Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice | Q44103922 | ||
Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice | Q44286385 | ||
Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The framingham heart study | Q44415952 | ||
Obesity and cardiovascular risk factors in Korean children and adolescents aged 10-18 years from the Korean National Health and Nutrition Examination Survey, 1998 and 2001. | Q44666173 | ||
The disease burden associated with overweight and obesity | Q44817527 | ||
Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women | Q44880994 | ||
Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study | Q44957764 | ||
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. | Q45032380 | ||
Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents | Q45335905 | ||
Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit | Q46480671 | ||
Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis | Q46536950 | ||
Epicardial adipose tissue and insulin resistance in obese subjects | Q46642982 | ||
Adiponectin and left ventricular structure and function in healthy adults | Q46656838 | ||
Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance | Q46664447 | ||
Randomized trial of lifestyle modification and pharmacotherapy for obesity | Q46807914 | ||
Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice | Q46818652 | ||
Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. | Q46866925 | ||
High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis | Q46935514 | ||
Body mass index is an independent determinant of left atrial size | Q47284347 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 55-61 | |
P577 | publication date | 2010-02-23 | |
P1433 | published in | Korean circulation journal | Q26842331 |
P1476 | title | Obesity and preclinical changes of cardiac geometry and function | |
P478 | volume | 40 |
Q37197090 | Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment |
Q90648178 | Cardiac function in adolescents with obesity: cardiometabolic risk factors and impact on physical fitness |
Q37525967 | High sodium intake in women with metabolic syndrome |
Q48235896 | Impact of obstructive sleep apnea on the global myocardial performance beyond obesity |